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ABSTRACT
Background and Objective: To determine whether the
NiTiNol frame of a novel hernia repair device utilizing
polypropylene mesh for inguinal hernioplasty remains
stable and intransient without fixation after a minimum of
6 months.
Methods: Twenty patients had 27 inguinal hernias re-
paired using a novel hernia repair device that has a Ni-
TiNol frame without any fixation. Initial single-view, post-
operative X-rays were compared with a second X-ray
obtained at least 6 months later. The NiTiNol frame, which
can be easily visualized on a plain X-ray, was measured in
2 dimensions, as were anatomic landmarks. The measure-
ments obtained and the appearances of the 2 X-rays were
compared to determine the percentage of change in de-
vice size and device stability with regard to device loca-
tion and shape.
Results: There were minimal changes noted between the
2 sets of measurements obtained with an overall trend
towards a slight increase in the size of the hernia repair
device. The devices demonstrated intransience of position
and stability of shape.
Conclusions: The NiTiNol frame of a novel hernia repair
device utilizing polypropylene mesh exhibits radiographic
evidence of size and shape stability and intransience of
position without fixation when used in inguinal hernio-
plasty after a minimum follow-up of 6 months.
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INTRODUCTION
Prosthetic meshes are routinely used to repair abdominal wall
hernias. One of the problems encountered with the available
mesh products is postimplantation shrinkage or distortion,
which can contribute to postoperative pain and hernia recur-
rence. The degree of shrinkage of polypropylene mesh has
been reported to be 33% to 54% in animal studies.1–3
Mesh contraction is known to occur within the first 2
months after implantation.3 Explanted mesh from humans
has been studied with regard to change in pore size and
has demonstrated changes from a 58.5% increase to a 40%
decrease; however, this study did not report on the overall
change in the size of the entire piece of mesh.4
The available data on mesh shrinkage in humans is limited
and includes a case report of an explanted piece of mesh
that had shrunk and folded to 30% of its original size in a
22-year-old man who had the mesh removed to treat
chronic pain.5 Other studies have reported mesh shrink-
age in the range of 20% to 30% for flat mesh and up to 75%
shrinkage with mesh plugs.6–8
Various types of fixation have been used to secure the
mesh in preperitoneal hernioplasty to prevent mesh dis-
location, which was seen consistently with no fixation and
is a recognized cause of hernia recurrence.9–10 Mesh fix-
ation however is associated with an increased incidence
of chronic postoperative pain after preperitoneal hernio-
plasty.10–12 Mesh fixation is not the only known cause for
chronic inguinodynia following hernia repair. Identified
causes of chronic inguinodynia include mechanical pres-
sure from mesh shrinkage or meshomas, periosteal reac-
tions, scar tissue, perineural fibrosis, neural compression
or traction, partial or complete nerve transection, as well
as nerve entrapment or injury by tacks, staples, or sutures
used for mesh fixation.13
Results from a swine study using a NiTiNol-framed hernia
device demonstrated no change in the radiographic ap-
pearance of the device from the immediate postoperative
X-ray and X-rays taken every 30 days until the final 90-day
X-rays. The swine were sacrificed, and the devices were
explanted and evaluated. There was no change in the size
or shape of the devices explanted from the swine after 3
months compared with a similar new device.14 This study
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SCIENTIFIC PAPERraised the question of whether similar results could be
demonstrated when the device is used to repair inguinal
hernias in humans.
PATIENTS AND MATERIALS
Twenty patients aged 17 to 89 years (mean age, 58.1,
median, 65) of which 17 were male and 3 were female had
27 inguinal hernias repaired utilizing an FDA-cleared Ni-
TiNol framed, polypropylene mesh, hernia device (NFHD)
(ReboundHRD®, MMDI, Plymouth, MN, USA). Five differ-
ent sizes and shapes of devices were utilized (Figure 1).
The decision as to which size or shape of device to use
was determined at the time of surgery. This decision was
based on the patient’s anatomy, the size of the hernia, and
the author’s preference. All of the procedures were per-
formed by the author at the Glacial Ridge Hospital in
Glenwood, Minnesota. The patients were evaluated with a
postoperative single view PA standing pelvis X-ray at a
30-degree caudal angle. The patients were then seen for
a clinical examination and repeat X-ray (also taken as a
30-degree caudal angle) standing PA of the pelvis to
assess the stability of the device after a minimum of 6
months postoperatively (range, 183 days to 341 days;
mean, 227; median, 224). There were 17 indirect, 2 direct,
and 8 indirect/direct (double or pantaloon) hernias re-
paired. Ten of the hernias were on the left, and 17 were on
the right. While under general anesthesia, all of the pa-
tients had laparoscopic TAPP repairs without any type of
device fixation. All of the initial postoperative X-rays and
late postoperative X-rays were independently reviewed
by 3 board certified radiologists. The NiTiNol frame of the
device is radio-opaque and can be well visualized on a
plain radiograph. Measurements of the device and skeletal
anatomic landmarks were obtained by using the measure-
ment function available with the PACS system [7 Medical
Systems 7i On Demand™ SUV Analysis tool (Standardized
Uptake Value)] on both sets of radiographs. To compen-
sate for any differences that were due to positioning or
distance differences, the measurements were equalized by
using the formula in Figure 2.
Measurements were compared for the cranial-caudal (CC)
and the medial-lateral or oblique (ML) dimensions for the
device and the patient’s skeletal anatomy (Figure 3). The
initial and late postoperative X-rays were compared and
measured (Figure 4) and the percentage of change for
each dimension (ML and CC) and a combined percentage
change was calculated. The X-rays were also evaluated for
radiographic evidence of any device distortion or position
change.
RESULTS
Comparison of the measurements from the first and sec-
ond radiographs (Table 1) revealed minimal change. Five
of the devices demonstrated a minimal decrease in size
between -0.2% and -1.6%, and in 22 of the devices there
was a slight expansion ranging between 0.3% to
11.3%. The mean change for all devices was 2.5% in
the cranial-caudal (CC) dimension and 1.6% in the
medial-lateral or oblique (ML) dimension. The overall
mean change was an increase of 2.0% in size. None of
the devices demonstrated any evidence of breakage, fray-
ing, or distortion of the NiTiNol frame. There was no
notable change in the radiographic appearance of any of
the devices with regard to device shape, contour, or po-
sition. None of the patients had developed a hernia recur-
rence. All of the patients were examined and interviewed Figure 1. Shapes and sizes of the NFHD devices used.
Figure 2. The formula above was used to correct for any confounding differences between the first and second X-ray measurements.
Such differences may be due to subtle variations in patient positioning, the distance between the patient and the X-ray tube, or both
of these.
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specifically questioned denied the presence of any pain,
discomfort, or awareness of the device.
DISCUSSION
The presence of the NiTiNol frame on this polypropylene
mesh hernia device demonstrated a consistent mainte-
nance of the radiographic appearance with regard to size,
shape, and position without fixation after a minimum of 6
months postimplantation. The stability of the shape and
size of the NiTiNol frame suggests that there would be
minimal shrinkage or distortion of the lightweight macro
porous polypropylene mesh used in this device as well.
The ability to image and monitor the status of the NiTiNol
frame (and indirectly the associated polypropylene mesh)
is a new option for surgeons and patients not previously
possible. This is accomplished with a plain, single-view
radiograph. It is well established that the “inguinal floor” is
a semi-concave 3-dimensional structure; however, the
2-dimensional imaging obtained with a plain radiograph
demonstrated consistency with regard to the shape, size,
and overall appearance of the devices evaluated.
Mesh shrinkage and “meshomas” are the result of fibrosis
and scar contraction. The NiTiNol frame in this device
keeps the mesh smooth and flat and provides a constant
circumferential outward tension on the mesh to prevent
wrinkling and contraction. The NiTiNol frame also affects
the peripheral edge of the polypropylene mesh in such a
way as to cause it to splay out which enhances the mesh
adherence to the adjacent tissue. This feature results in a
“Velcro-like” effect that stabilizes the device where posi-
tioned and contributes to the intransience of the device.
This device therefore does not require any fixation, and
no fixation of any type was used in any of the patients in
this study. The ability to avoid mesh fixation eliminates
the potential injury or impingement of nerves and blood
vessels and also avoids the potential sites of traction that
can be a source of pain from misplaced tacks or staples.
The device is designed to conform to the patient’s anat-
omy, and this self-seating feature may account for some of
the minimal changes noted in the X-ray measurements.
Figure 3. The cranial-caudal (CC) and medial-lateral or oblique
(ML) measurements of the NiTiNol frame and anatomic land-
marks using the measurement function available with the PACS
system [7 Medical Systems 7i On Demand™ SUV Analysis tool
(Standardized Uptake Value)].
Figure 4. Side-by-side comparison measurements of the initial
postoperative X-ray and the second postoperative X-ray (taken
after a minimum of 6 months postoperatively).
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overall increase in the size of his device. When comparing
the first and second postoperative X-rays, it becomes
apparent that the change is likely due to the overall ex-
pansion of the device. I believe this is the consequence of
an inadequate preperitoneal dissection preventing the de-
vice from completely unfurling at the time of placement.
In this case, the device expanded to the fully unfurled size
and shape as seen on the second X-ray taken 292 days
later (Figure 5).
Table 1.
The measurements in Table 1 are obtained from the initial and second X-rays (greater than 6 months postoperatively).
Measurements of the NiTiNol frame and the anatomic landmarks in the cranial-caudal (CC) and medial-lateral or oblique (ML)
dimensions are listed for both sets of X-rays. The percentage of change is calculated by using the formula in Figure 2
1ST X-ray
a 2nd X-ray
a %change
a
Patient, Age, Sex,
Device Type
Location & Type
of Hernia
NFHD NFHD Pt Pt NFHD NFHD Pt Pt NFHD NFHD NFHD
CC ML CC ML CC ML CC ML CC ML Average
1) 86 M, Hybrid Indirect L 129 100 143 362 125 97 140 359 1.0% 2.2% 1.6%
2) 46 M, Hybrid Direct/Indirect R 100 97 167 243 109 114 181 269 0.6% 6.8% 3.7%
3) 46 M, Hybrid Direct/Indirect L 117 105 158 297 145 112 183 338 8.1% 7.1% 0.5%
4) 89 M, Hybrid Indirect R 136 123 215 324 132 120 205 316 1.7% 0.0% 0.9%
5) 89 M, Hybrid Indirect L 141 91 215 324 133 95 205 316 1.0% 6.9% 2.9%
6) 76 M, Hybrid Direct/Indirect R 116 112 140 423 129 115 135 401 14.8% 7.9% 11.3%
7) 27 M, Hybrid Indirect R 120 122 175 309 134 124 176 323 11.1% 2.9% 4.1%
8) 65 F, Dog Bone Indirect R 109 104 120 322 116 110 120 329 6.4% 3.6% 5.0%
9) 27 M, Hybrid Indirect R 127 117 363 388 130 111 366 376 1.5% 2.0% 0.2%
10) 27 M, Hybrid Indirect L 130 121 363 388 133 115 366 376 1.5% 1.9% 0.2%
11) 81 M, Hybrid Direct/Indirect L 125 114 144 368 127 115 143 360 2.3% 3.0% 2.7%
12) 29 M, Hybrid Direct/Indirect R 97 149 177 336 98 145 177 327 1.0% 0.0% 0.5%
13) 53 M, SM Shield Indirect R 123 132 183 365 123 133 170 366 7.1% 0.5% 3.8%
14) 45 M, LG Shield Direct R 185 168 154 342 191 168 163 343 2.1% 0.3% 1.4%
15) 45 M, LG Shield Direct L 181 149 163 368 187 158 175 369 4.0% 5.8% 0.9%
16) 87 M, LG Hybrid Direct/Indirect R 80 118 156 374 82 119 161 368 0.7% 2.4% 0.9%
17) 17 F, Hybrid Indirect R 128 124 149 329 131 126 150 332 1.7% 0.7% 1.2%
18) 44 M, LG Shield Indirect R 154 136 171 247 155 147 167 251 3.0% 6.5% 4.7%
19) 44 M, SM Shield Indirect L 131 113 171 247 126 115 167 251 1.5% 0.1% 0.7%
20) 75 M, SM Shield Indirect L 72 130 164 243 68 127 146 227 5.4% 4.3% 4.8%
21) 71 M, LG Shield Direct/Indirect R 180 159 236 320 184 158 235 320 2.6% 0.3% 1.0%
22) 70 M, LG Shield Direct/Indirect R 187 150 188 343 188 152 184 344 2.7% 1.0% 1.8%
23) 79 M, LG Hybrid Indirect R 149 150 183 387 131 161 163 397 1.1% 4.7% 0.6%
24) 79 M, LG Hybrid Indirect L 159 153 193 387 135 158 163 397 0.4% 0.7% 0.6%
25) 65 F, SM Hybrid Indirect R 102 131 346 344 101 129 339 340 1.0% 0.4% 0.3%
26) 30 M, LG Hybrid Indirect R 192 156 163 397 182 153 149 371 3.4% 4.6% 4.0%
27) 30 M, LG Hybrid Indirect L 181 149 163 397 169 139 149 371 2.0% 0.2% 0.9%
Average % Change 2.5% 1.6% 2.0%
aNFHDNiTiNol Framed Hernia Device, PtPatient, CCCranial-Caudal Measurement, MLMedial, Lateral, or Oblique Measurement.
All measurements are in mm.
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The radiographic appearance of the NiTiNol-framed, poly-
propylene mesh hernia device remains stable with regard to
size, shape, and position 6 months after implantation when
used for laparoscopic inguinal hernioplasty. The radio-
graphic appearance of the device remained stable during the
critical period of tissue ingrowth without the use of any
fixation. The NiTiNol frame of this device provides the sur-
geon with a new option–the ability to consistently image a
hernia device with a single-view plain radiograph. The reli-
ability of the performance of the NiTiNol-framed hernia de-
vice in this initial study is encouraging. A larger trial with an
extended follow-up interval of this device is warranted.
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Figure 5. Side-by-side comparison of the initial and second
X-ray (292 days postoperatively) of the outlier patient who had
an 11.33% overall increase in size.
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